-
Signature
-
/s/ John S. Hess, Jr. under Power of Attorney
-
Issuer symbol
-
UTHR
-
Transactions as of
-
24 Dec 2025
-
Net transactions value
-
-$4,038,624
-
Form type
-
4
-
Filing time
-
29 Dec 2025, 16:31:22 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| MAHON PAUL A |
EVP & GENERAL COUNSEL |
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING |
/s/ John S. Hess, Jr. under Power of Attorney |
29 Dec 2025 |
0001231589 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$1,606,330 |
+11,000 |
+30% |
$146.03 |
47,781 |
24 Dec 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$255,627 |
-502 |
-1.1% |
$509.22 |
47,279 |
24 Dec 2025 |
Direct |
F1, F2 |
| transaction |
UTHR |
Common Stock |
Sale |
$70,354 |
-138 |
-0.29% |
$509.81 |
47,141 |
24 Dec 2025 |
Direct |
F1, F3 |
| transaction |
UTHR |
Common Stock |
Sale |
$20,426 |
-40 |
-0.08% |
$510.64 |
47,101 |
24 Dec 2025 |
Direct |
F1, F4 |
| transaction |
UTHR |
Common Stock |
Sale |
$1,474,726 |
-2,877 |
-6.1% |
$512.59 |
44,224 |
24 Dec 2025 |
Direct |
F1, F5 |
| transaction |
UTHR |
Common Stock |
Sale |
$2,419,948 |
-4,713 |
-11% |
$513.46 |
39,511 |
24 Dec 2025 |
Direct |
F1, F6 |
| transaction |
UTHR |
Common Stock |
Sale |
$1,362,589 |
-2,650 |
-6.7% |
$514.18 |
36,861 |
24 Dec 2025 |
Direct |
F1, F7 |
| transaction |
UTHR |
Common Stock |
Sale |
$41,285 |
-80 |
-0.22% |
$516.06 |
36,781 |
24 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-11,000 |
-54% |
$0.000000 |
9,250 |
24 Dec 2025 |
Common Stock |
11,000 |
$146.03 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: